Overview

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of BMS-247550 in treating patients who have liver or gallbladder cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Epothilone B
Epothilones